Skip to main content
APGE
NASDAQ Life Sciences

AbbVie Nears $10.9B Cash Deal to Acquire Apogee Therapeutics, Shares Surge 53%

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$138.49
Mkt Cap
$6.814B
52W Low
$34.34
52W High
$95.315
52W Position info
303% above low
Off High info
at 52W high
Rel. Volume info
2.0× avg
Market data snapshot near publication time

APGE has more than doubled off its 52-week low of $34.34 on elevated volume (2.0× avg).

Summary

AbbVie is reportedly nearing a $10.9 billion cash deal to acquire Apogee Therapeutics, according to the Financial Times. This potential acquisition represents a substantial 60% premium over Apogee's recent closing price, causing shares to surge 53% in premarket trading. The news follows highly positive Phase 2 results for Apogee's lead drug candidate, zumilokibart, reported in late May, which likely increased its attractiveness. This would be a significant exit for shareholders, validating the company's pipeline. A formal announcement could come as early as today.

At the time of this announcement, APGE was trading at $138.49 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $6.8B. The 52-week trading range was $34.34 to $95.32. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

APGE - Latest Insights

APGE
Sep 03, 2026, 8:53 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $135.11
Real-time Price: $135.11 info
Change: $0 (0%) info
Market Cap: $10.223B info
APGE
Aug 11, 2026, 4:00 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $134.69
Real-time Price: $135.11 info
Change: +$0.420 (+0.31%) info
Market Cap: $10.223B info
APGE
Aug 10, 2026, 7:52 AM EDT
Filing Type: 10-Q
Importance Score:
10
Price at Filing: $134.62
Real-time Price: $135.11 info
Change: +$0.486 (+0.36%) info
Market Cap: $10.223B info
APGE
Aug 10, 2026, 7:19 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $134.79
Real-time Price: $135.11 info
Change: +$0.320 (+0.24%) info
Market Cap: $10.223B info
APGE
Aug 06, 2026, 6:31 AM EDT
Filing Type: DEFA14A
Importance Score:
8
Price at Filing: $134.27
Real-time Price: $135.11 info
Change: +$0.840 (+0.63%) info
Market Cap: $10.223B info